Wednesday, October 23, 2024
HomeTagsNeuropsychiatric medicines

neuropsychiatric medicines

Seaport Therapeutics Secures $225M in Oversubscribed Series B Round

Seaport Therapeutics, a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, announced the closing of an oversubscribed...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics